Pharmaceutical Services Regulations (Northern Ireland) 1997

Regulation 13 and Schedule 2 paragraph 9(5)

SCHEDULE 5 PHARMACEUTICAL COMMITTEE

1.  The Pharmaceutical Committee constituted by the Agency after consultation with the Boards and such organisation which is, in the opinion of the Agency, representative of the general body of chemists and such other persons as it considers appropriate, shall consist of a chairman and such number of other members as the Agency thinks fit.

2.  The chairman shall be a pharmacist appointed by the Department.

3.  The term of office of members shall be determined by the Agency.

4.  Where the place of a member becomes vacant before the expiration of his term of office whether by death, resignation or otherwise, the vacancy shall be filled by the Agency after consultation in accordance with paragraph 1 and if necessary with the Pharmaceutical Committee and any other person so appointed shall hold office for the remainder of the term of office of the member who died, resigned or otherwise vacated his office as the case may be.

5.  A member of the Pharmaceutical Committee may resign his membership by giving to the Agency notice in writing.

6.  Where any member of the Pharmaceutical Committee—

(a) is absent from the meetings of the Committee for more than 6 months consecutively (except for a reason approved by the Agency);

(b) has become bankrupt or has made a composition with his creditors; or

(c) is convicted of an indictable offence;

the Agency shall forthwith by resolution, declare the office to be vacant and shall notify that fact in such manner as it thinks fit and thereupon the office shall become vacant.

7.  A member of the Pharmaceutical Committee may vote upon any matter which touches the interests of members of his profession (himself included) but shall not vote upon any matters touching only his individual professional interests.

8.  The proceedings of the Pharmaceutical Committee shall not be invalidated by any vacancy in the membership of the Committee or by any defect in the appointment of its members.

9.  A member of the Pharmaceutical Committee who is a member of a Board shall cease to be a member of that Committee if he ceases to be a member of that Board.